Naglie Gary
Division of General Internal Medicine, University Health Network, Canada.
Can J Neurol Sci. 2007 Mar;34 Suppl 1:S57-61. doi: 10.1017/s0317167100005588.
There is a growing consensus that quality of life (QOL) is an important outcome for assessing the effectiveness of interventions for dementia, but there is no agreement about how to best measure it. Various approaches to QOL assessment have been employed to measure the QOL of persons with dementia, including patient self-report, caregiver proxy report and observational assessment by trained observers. Furthermore, several dementia-specific measures of QOL have been developed, and several generic measures of QOL have been used to assess QOL in dementia. However, to date, QOL has rarely been included as an outcome measure in clinical trials of pharmacotherapy for dementia. This manuscript reviews the current state of knowledge about QOL assessment in dementia.
人们越来越一致地认为,生活质量(QOL)是评估痴呆症干预措施有效性的重要结果,但对于如何最好地衡量它尚无共识。已采用各种生活质量评估方法来衡量痴呆症患者的生活质量,包括患者自我报告、护理人员代理报告以及由训练有素的观察员进行的观察性评估。此外,已经开发了几种针对痴呆症的生活质量特定测量方法,并且已经使用了几种通用的生活质量测量方法来评估痴呆症患者的生活质量。然而,迄今为止,生活质量在痴呆症药物治疗的临床试验中很少被纳入作为结果测量指标。本手稿综述了目前关于痴呆症生活质量评估的知识状况。